Molecule Details
| InChIKey | OJMWMNBVLAUFIE-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-[2-[4-(4-Methylanilino)piperidin-1-yl]ethyl]benzenesulfonamide |
| Canonical SMILES | Cc1ccc(NC2CCN(CCc3ccc(S(N)(=O)=O)cc3)CC2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 8 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.19 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (8)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O43570 | CA12 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL |
| P43166 | CA7 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL |
| P00918 | CA2 | Homo sapiens | Human | PF00194 | 7.5 | Ki | ChEMBL |
| Q16790 | CA9 | Homo sapiens | Human | PF00194 | 7.3 | Ki | ChEMBL |
| Q9ULX7 | CA14 | Homo sapiens | Human | PF00194 | 7.2 | Ki | ChEMBL |
| P00915 | CA1 | Homo sapiens | Human | PF00194 | 7.0 | Ki | ChEMBL |
| P35218 | CA5A | Homo sapiens | Human | PF00194 | 7.0 | Ki | ChEMBL |
| Q8N1Q1 | CA13 | Homo sapiens | Human | PF00194 | 6.2 | Ki | ChEMBL |